An injectable shape-adaptive hydrogel system for subconjunctival injuries: In situ and permanently releases rapamycin to prevent fibrosis via promoting autophagy
Subconjunctival fibrosis (SCF) is a common and refractory eye disease that is a serious threat to vision. The severe side effects of existing drugs and low drug bioavailability due to the ocular barrier are major challenges in SCF treatment. Hence, there is an urgent need to explore safer and more e...
Saved in:
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Materials Today Bio |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590006424004411 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841533308254552064 |
---|---|
author | Xue Sun Haohao Cui Jingfan Li Boyuan An Ruixing Liu Zhihua Guo Dandan Chu Xingchen Geng Bingbing Cui Lei Zhu Jingguo Li Zhanrong Li |
author_facet | Xue Sun Haohao Cui Jingfan Li Boyuan An Ruixing Liu Zhihua Guo Dandan Chu Xingchen Geng Bingbing Cui Lei Zhu Jingguo Li Zhanrong Li |
author_sort | Xue Sun |
collection | DOAJ |
description | Subconjunctival fibrosis (SCF) is a common and refractory eye disease that is a serious threat to vision. The severe side effects of existing drugs and low drug bioavailability due to the ocular barrier are major challenges in SCF treatment. Hence, there is an urgent need to explore safer and more effective strategies for administering anti-SCF drugs. Herein, an injectable and adaptable hydrogel system containing the antifibrotic drug rapamycin was fabricated to address this complex need. This system possesses moderate mechanical properties, self-healing and shape-adaptive capabilities, injectability, and biosafety. It is designed to promote autophagy by modulating the PI3K/AKT/mTOR/WIPI2 pathway, thereby inhibiting SCF. In vivo experiments utilizing a rat subconjunctival injury model indicated that in situ administration of this hydrogel system effectively inhibited SCF. This system constitutes a promising method for promoting autophagy to protect against SCF, which will foster its widespread application for other fibrotic diseases. |
format | Article |
id | doaj-art-6a85c3844308497b88015998cb96e734 |
institution | Kabale University |
issn | 2590-0064 |
language | English |
publishDate | 2025-02-01 |
publisher | Elsevier |
record_format | Article |
series | Materials Today Bio |
spelling | doaj-art-6a85c3844308497b88015998cb96e7342025-01-17T04:52:01ZengElsevierMaterials Today Bio2590-00642025-02-0130101380An injectable shape-adaptive hydrogel system for subconjunctival injuries: In situ and permanently releases rapamycin to prevent fibrosis via promoting autophagyXue Sun0Haohao Cui1Jingfan Li2Boyuan An3Ruixing Liu4Zhihua Guo5Dandan Chu6Xingchen Geng7Bingbing Cui8Lei Zhu9Jingguo Li10Zhanrong Li11Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaCorresponding author.; Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaCorresponding author.; Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaSubconjunctival fibrosis (SCF) is a common and refractory eye disease that is a serious threat to vision. The severe side effects of existing drugs and low drug bioavailability due to the ocular barrier are major challenges in SCF treatment. Hence, there is an urgent need to explore safer and more effective strategies for administering anti-SCF drugs. Herein, an injectable and adaptable hydrogel system containing the antifibrotic drug rapamycin was fabricated to address this complex need. This system possesses moderate mechanical properties, self-healing and shape-adaptive capabilities, injectability, and biosafety. It is designed to promote autophagy by modulating the PI3K/AKT/mTOR/WIPI2 pathway, thereby inhibiting SCF. In vivo experiments utilizing a rat subconjunctival injury model indicated that in situ administration of this hydrogel system effectively inhibited SCF. This system constitutes a promising method for promoting autophagy to protect against SCF, which will foster its widespread application for other fibrotic diseases.http://www.sciencedirect.com/science/article/pii/S2590006424004411Subconjunctival fibrosisRapamycinIn situ hydrogelAutophagy |
spellingShingle | Xue Sun Haohao Cui Jingfan Li Boyuan An Ruixing Liu Zhihua Guo Dandan Chu Xingchen Geng Bingbing Cui Lei Zhu Jingguo Li Zhanrong Li An injectable shape-adaptive hydrogel system for subconjunctival injuries: In situ and permanently releases rapamycin to prevent fibrosis via promoting autophagy Materials Today Bio Subconjunctival fibrosis Rapamycin In situ hydrogel Autophagy |
title | An injectable shape-adaptive hydrogel system for subconjunctival injuries: In situ and permanently releases rapamycin to prevent fibrosis via promoting autophagy |
title_full | An injectable shape-adaptive hydrogel system for subconjunctival injuries: In situ and permanently releases rapamycin to prevent fibrosis via promoting autophagy |
title_fullStr | An injectable shape-adaptive hydrogel system for subconjunctival injuries: In situ and permanently releases rapamycin to prevent fibrosis via promoting autophagy |
title_full_unstemmed | An injectable shape-adaptive hydrogel system for subconjunctival injuries: In situ and permanently releases rapamycin to prevent fibrosis via promoting autophagy |
title_short | An injectable shape-adaptive hydrogel system for subconjunctival injuries: In situ and permanently releases rapamycin to prevent fibrosis via promoting autophagy |
title_sort | injectable shape adaptive hydrogel system for subconjunctival injuries in situ and permanently releases rapamycin to prevent fibrosis via promoting autophagy |
topic | Subconjunctival fibrosis Rapamycin In situ hydrogel Autophagy |
url | http://www.sciencedirect.com/science/article/pii/S2590006424004411 |
work_keys_str_mv | AT xuesun aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT haohaocui aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT jingfanli aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT boyuanan aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT ruixingliu aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT zhihuaguo aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT dandanchu aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT xingchengeng aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT bingbingcui aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT leizhu aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT jingguoli aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT zhanrongli aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT xuesun injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT haohaocui injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT jingfanli injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT boyuanan injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT ruixingliu injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT zhihuaguo injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT dandanchu injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT xingchengeng injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT bingbingcui injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT leizhu injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT jingguoli injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy AT zhanrongli injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy |